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ABSTRACT Mammalian lipopolysaccharide (LPS) binding proteins (LBPs) occur mainly in extracellular fluids and promote LPS
delivery to specific host cell receptors. The function of LBPs has been studied principally in the context of host defense; the possi-
ble role of LBPs in nonpathogenic host-microbe interactions has not been well characterized. Using the Euprymna scolopes-
Vibrio fischeri model, we analyzed the structure and function of an LBP family protein, E. scolopes LBP1 (EsLBP1), and provide
evidence for its role in triggering a symbiont-induced host developmental program. Previous studies showed that, during initial
host colonization, the LPS of V. fischeri synergizes with peptidoglycan (PGN) monomer to induce morphogenesis of epithelial
tissues of the host animal. Computationally modeled EsLBP1 shares some but not all structural features of mammalian LBPs
that are thought important for LPS binding. Similar to human LBP, recombinant EsLBP1 expressed in insect cells bound V. fis-
cheri LPS and Neisseria meningitidis lipooligosaccharide (LOS) with nanomolar or greater affinity but bound Francisella tular-
ensis LPS only weakly and did not bind PGN monomer. Unlike human LBP, EsLBP1 did not bind N. meningitidis LOS:CD14
complexes. The eslbp1 transcript was upregulated ~22-fold by V. fischeri at 24 h postinoculation. Surprisingly, this upregulation
was not induced by exposure to LPS but, rather, to the PGN monomer alone. Hybridization chain reaction-fluorescent in situ
hybridization (HCR-FISH) and immunocytochemistry (ICC) localized eslbp1 transcript and protein in crypt epithelia, where
V. fischeri induces morphogenesis. The data presented here provide a window into the evolution of LBPs and the scope of their
roles in animal symbioses.
IMPORTANCE Mammalian lipopolysaccharide (LPS)-binding protein (LBP) is implicated in conveying LPS to host cells and po-
tentiating its signaling activity. In certain disease states, such as obesity, the overproduction of this protein has been a reliable
biomarker of chronic inflammation. Here, we describe a symbiosis-induced invertebrate LBP whose tertiary structure and LPS-
binding characteristics are similar to those of mammalian LBPs; however, the primary structure of this distantly related squid
protein (EsLBP1) differs in key residues previously believed to be essential for LPS binding, suggesting that an alternative strat-
egy exists. Surprisingly, symbiotic expression of eslbp1 is induced by peptidoglycan derivatives, not LPS, a pattern converse to
that of RegIII, an important mammalian immunity protein that binds peptidoglycan but whose gene expression is induced by
LPS. Finally, EsLBP1 occurs along the apical surfaces of all the host’s epithelia, suggesting that it was recruited from a general
defensive role to one that mediates specific interactions with its symbiont.
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Over the last decade, several studies have demonstrated thatmutualistic and pathogenic associations share a molecular
language (for reviews, see references 1 and 2). Key elements of this
dialogue are microbe-associated molecular patterns (MAMPs) of
microbial cell surfaces, including lipopolysaccharide (LPS) and
peptidoglycan (PGN) derivatives, and their cognate host sensors
and receptors. The model mutualistic association between the Ha-
waiian bobtail squid Euprymna scolopes and the bioluminescent
marine bacterium Vibrio fischeri has provided an experimental
system for the study of these interactions. In the squid-vibrio as-
sociation, symbiont lipid A, the lipid component of LPS, and the
PGN monomer tracheal cytotoxin (TCT) direct various
symbiont-induced developmental programs of the squid’s light
organ, the set of tissues that harbors the symbionts and modifies
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their luminescence for use in host behaviors. MAMP-induced
morphogenetic programs include the apoptotic loss of the ciliated
epithelium that potentiates initial colonization, recruitment of
macrophagelike blood cells into the organ, and the transforma-
tion of the biochemical environment where the symbionts take up
residence in host tissues (for reviews, see references 3 and 4). The
luminescence from the V. fischeri monoculture in the light organ
allows E. scolopes to match ambient light and thereby disguise its
shadow (5). Subsequent studies in mammals have demonstrated
that MAMPs also drive development, such as immune system
maturation, in complex host-microbial associations, including in
the mammalian gut (2). This study uses the squid-vibrio model to
provide experimental evidence for the role of lipopolysaccharide-
binding protein (LBP), a member of the LBP/BPI (bactericidal/
permeability-increasing protein) protein family, as a key player in
host responses to symbiont LPS.
As MAMP recognition proteins, mammalian LBP and BPI are
closely related, structurally similar proteins that serve comple-
mentary roles in innate immunity. LBP relays LPS to host cells,
whereas BPI acts as a bactericidal/LPS-neutralizing effector mol-
ecule to help clear infection and resolve infection-induced inflam-
mation (6, 7). LBP is present in plasma and tissue fluids, and
recent reports have determined that LBP and BPI are expressed in
the gut and other epithelia, where they likely mediate responses to
the interfacing microbiota (8, 9). During an inflammatory re-
sponse, the constitutively present levels of LBP are sufficient to
catalyze extraction and delivery of individual LPS molecules to
CD14 and MD-2/TLR4 to induce potent proinflammatory re-
sponses (10–13). LBP levels can increase up to 100-fold during
acute-phase reactions following the initial inflammatory re-
sponses, promoting, along with BPI, noninflammatory clearance
of LPS and eventual resolution of LPS-triggered inflammation
(11, 14, 15). Unlike BPI, LBP binding to Gram-negative bacteria
(e.g., Escherichia coli) does not produce lethal or sublethal altera-
tions of the bacteria (16).
Despite differences in activity between mammalian LBP and
BPI, the structural organization conferring function is generally
similar. Thus, the N-terminal domain of each protein binds LPS,
whether presented in the form of intact Gram-negative bacteria
(16, 17), shed outer membrane blebs, or aggregates of purified LPS
(18–20). The C-terminal domain of both LBP and BPI is respon-
sible for delivery of the bound LPS-containing material to host
cells (18, 20, 21). Conserved, positively charged residues near the
N-terminal tip of both mammalian LBP and BPI are likely impor-
tant in initial electrostatic interactions with typically polyanionic
LPS (22–25). The net cationicity is greater in BPI than in LBP in
both the charged N-terminal tip and across the molecule; the iso-
electric point (pI) of LBP is near neutral, whereas the BPI pI is ~10.
This difference in charge likely accounts for the higher LPS- and
bacterial-binding affinity of BPI and the distinct effects that LBP
and BPI produce on LPS-rich interfaces, including bacterial outer
membranes (21, 26). BPI causes bacterial sublethal and lethal in-
jury, whereas LBP promotes extraction of individual LPS mole-
cules by CD14 at substoichiometric concentrations (12, 19).
Although the gene duplication giving rise to mammalian LBP
and BPI is believed to have occurred after the radiation of the
mammals (27), related proteins have been reported in several in-
vertebrate groups (28, 29). While a given invertebrate species may
have multiple LBP/BPI gene isoforms, an LBP/BPI dichotomy has
not been well characterized outside the mammals. Sequence anal-
ysis across the animal kingdom shows that these proteins are rel-
atively quickly evolving, with ~21% identity between E. scolopes
LBP1 (EsLBP1) and mammalian LBP/BPI proteins, indicating
~1% change in the amino acid sequence every 7 million years. A
comparative analysis of structure and function across these deep
divergences that have occurred over more than 500 million years
offers the opportunity to define biochemical features that are es-
sential for function of these molecules, as well as to explore how
evolutionary tinkering can give rise to diversity of function.
Full-length transcripts of four members of the LBP/BPI pro-
tein family have been identified in E. scolopes (28, 30). One of these
proteins, EsLBP1 (previously called EsLBP [31]), is of particular
interest as a candidate for responding to symbiont LPS during
development. The pI of EsLBP1 is near neutral, suggesting that it
functions similarly to mammalian LBPs, i.e., presenting LPS as a
signal molecule. In addition, the gene encoding EsLBP1 increases
in expression at 18 h following the onset of host-symbiont inter-
action, a time when morphogenesis is being signaled by MAMPs
(31). In the present study, to provide insight into the possible role
of an LBP in inducing an animal developmental program, we
sought to characterize the biochemical properties of EsLBP1,
comparing them to those of mammalian LBP, and to examine the
timing and location of EsLBP1 gene expression and protein pro-
duction through the early trajectory of host development.
RESULTS
Structural comparison of LPS-binding domain of mammalian
LBP and BPI to corresponding region of EsLBP1. We focused on
the LPS-binding N-terminal domain of human LBP/BPI (hLBP/
hBPI) proteins for comparison with EsLBP1 by primary sequence
alignment (Fig. 1A). Overall, the degree of conservation with hu-
man LBP/BPI proteins is limited; EsLBP1 is 23.6% identical to
hBPI and 25.7% identical to hLBP within this region. In contrast
to the extensive differences in overall primary structure, the poly-
cationic region of mammalian BPI and LBP most strongly impli-
cated in LPS binding (residues 86 to 102) (22–24) also represents
the most cationic local region of EsLBP1 (Fig. 1A). The sequence
alignment of human and squid proteins predicts that the disulfide
bond of the mammalian LBP/BPI family within the N-terminal
domain (32) is conserved in EsLBP1 (Fig. 1A). The tertiary struc-
ture of EsLBP1, as derived by SWISS-MODEL, is most similar to
the 2.40-Å structure of human BPI (SMTL accession number
1BP1.1.A) (22). The QMEAN4 score, a protein model quality
measure based on scoring functions like torsion and solvation that
are related to model geometry (33), is 5.63 (Fig. 1B). Thus, the
overall model quality is low, i.e., confidence that the three-
dimensional (3-D) structure of BPI can predict that of EsLBP1 is
limited. However, it should be noted that the model quality varies
greatly by region (Fig. 1B), conforming well in the extended pro-
tein regions that define the unique boomeranglike configuration
of mammalian LBP and BPI (22, 34) but deviating greatly in re-
gions in both the N- and C-terminal domains that impart inter-
active properties specific to LBP or BPI. For example, the highest
net concentration of positive charge present in mammalian BPI
and LBP, at the tip region of the N-terminal domain (Fig. 1D and
E), is also manifest in EsLBP1 (Fig. 1C) but in an area of high
divergence from the template. The residues predicted by Clust-
alW2 alignment to be involved in the conserved disulfide bond
(Fig. 1A) are in an area of relatively good fit to the BPI template
and in close proximity to each other, as in human BPI (Fig. 1F and
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G). The choice of template structure, human BPI or mouse LBP,
for the EsLBP1 model did not affect these general characteristics.
LOS-/LPS-binding properties of EsLBP1. The structural
comparisons described above are consistent with the LPS-binding
properties of EsLBP1. To test this hypothesis more directly, we
assayed the binding of metabolically labeled (3H) meningococcal
lipooligosaccharide (LOS) to recombinant His-tagged EsLBP1.
Binding was measured by quantifying cocapture of the radiola-
beled LOS by nickel beads to which His-tagged proteins bind.
Cocapture of [3H]LOS was dependent on the dose of conditioned
medium containing EsLBP1. Control conditioned medium lack-
ing EsLBP1 produced significantly lower cocapture of [3H]LOS,
without dose dependency. High levels of cocapture occurred fol-
lowing incubations of 1 nM LOS with ~0.1 to 1 nM EsLBP1, in-
dicating very-high-affinity binding of meningococcal LOS to the
squid protein (Fig. 2A). Preincubation of EsLBP1 with compara-
ble amounts of unlabeled Neisseria meningitidis or V. fischeri LOS/
LPS (up to 100-fold excess) prior to its addition to and incubation
with [3H]LOS reduced cocapture of [3H]LOS radiolabeled sub-
strate. Francisella tularensis LPS, which binds human LBP poorly
(35), only caused this decrease in capture when added in 100-fold
excess of the [3H]LOS (Fig. 2B).
As mammalian LBP has a role in binding pneumococcal cell
wall fragments (36), we sought to determine whether EsLBP1
binds the peptidoglycan monomer, TCT. Additionally, human
LBP reacts with monomeric endotoxin:CD14 complexes to form
supramolecular complexes containing LBP, endotoxin, and CD14
(J. P. Weiss unpublished data). We adapted the LOS/LPS capture
assay described above to measure binding to [3H]TCT and to
[3H]LOS:human CD14 complexes, but in neither case was
EsLBP1-dependent cocapture observed (Fig. 2C and D). Thus, we
found no evidence for EsLBP1 binding of TCT or LOS:CD14 com-
plexes.
EsLBP1 does not kill Escherichia coli. The pI of EsLBP1 sug-
gests that it more likely functions like LBP and not BPI. To test this
hypothesis more directly, we assayed the effects of EsLBP1 and, for
comparison, recombinant human LBP and BPI-21 (the LPS-
binding and bactericidal N-terminal Mr 21,000 fragment of hu-
man BPI [37]) on the viability of E. coli. As shown previously (16,
17), BPI but not LBP produced killing of E. coli, as manifested by
reduced CFU (Fig. 3). At the same protein concentration tested,
EsLBP1 had no effect on bacterial viability, resembling mamma-
lian LBP.
eslbp1 transcript expression is induced by symbiosis and
TCT but not by the binding partner, LPS. Previous microarray
results (31) showed that EsLBP1 is upregulated at 18 h following
colonization of E. scolopes by V. fischeri, i.e., following the first full
colonization of host crypts. Here, we used quantitative reverse
transcriptase PCR (qRT-PCR) with gene-specific primer sets (see
Table S1 in the supplemental material) to establish the time course
of eslbp1 expression over the trajectory of early development. We
also investigated the role of symbiont MAMPs in the induction of
FIG 1 Characteristics of the EsLBP1 protein. (A) Amino acid sequence align-
ment of N-terminal LBP/BPI domains of human BPI (hBPI), human LBP
(hLBP), and EsLBP1. Cysteine residues of the conserved disulfide bond (32)
are color coded in yellow, negatively charged residues (Glu, asp) in red, and
positively charged residues (Arg, Lys) in blue. Numbering for human LBP and
BPI is based on the system in reference 32. (B) SWISS-MODEL-predicted 3-D
structure of EsLBP1 based on human BPI template (SMTL accession number
1BP1.1.A). Color gradient shown in key indicates quality of structure as deter-
mined by local QMEAN4 score. Dashed boxes show regions depicted in panels
C and F. (C) N-terminal tip of EsLBP1 model from panel B. Charged amino
acids are color coded as blue for positive residues (Arg, Lys) and red for neg-
ative residues (Glu, Asp). (D) Corresponding N-terminal region in human BPI
structure, marked for charge as described for panel C. (E) Corresponding
(Continued)
Figure Legend Continued
N-terminal region in mouse LBP (SMTL accession number 4m4d.1), marked
for charge as described for panel C. (F) Region of predicted disulfide bond in
EsLBP1 structure, with the positions of side chains of residues C140 and C175
indicated. Colors of backbone illustration depict QMEAN4 score as shown by
the key in panel B. (G) Region of disulfide bond in human BPI structure, with
the positions of side chains of residues C135 and C175 indicated.
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eslbp1. A reproducible, significant, ~3-fold difference in eslbp1
expression between aposymbiotic and symbiotic light organs was
first observed at 12 h postinoculation; the degree of upregulation
in symbiotic over aposymbiotic light organs at 24 h varied but was
typically greater than 20-fold (Fig. 4A). Lipid A, the LPS derivative
involved in symbiont-induced development, from either V. fisch-
eri or E. coli was used at 10 ng/ml, a level that optimally induces
host cell phenotypes, but it did not induce changes in eslbp1 ex-
pression. However, TCT added at 1 M was shown to increase
eslbp1 ~11-fold over the background level; the TCT effect was not
further amplified by the addition of lipid A (Fig. 4B and C).
eslbp1 transcripts localize to light organ tissues interfacing
with V. fischeri. Using hybridization chain reaction-fluorescent in
situ hybridization (HCR-FISH), we localized the expression of
eslbp1 within the light organ to determine whether the gene is
expressed in proximity to V. fischeri and to ascertain the steps of
the establishment of symbiosis in which EsLBP1 may play a role.
We evaluated the locations of transcripts in light organs at 24 h
postinoculation using gene-specific probes for eslbp1, for hsp90
(as a counterstain for E. scolopes tissue), and for V. fischeri 16S
ribosomal subunit (to label the symbionts) (see Table S2 in the
supplemental material). eslbp1 transcript signals in symbiotic light
organs were elevated relative to the levels in nonsymbiotic light
organs throughout the epithelial surfaces closely associated with
V. fischeri, including the pores, ducts, and crypts of the organ
(Fig. 5).
EsLBP1 protein is present at epithelial surfaces that directly
associate with bacteria and with the environment. We compared
the data on the localization of eslbp1 transcripts and of protein.
Using chicken anti-EsLBP1 antibody, we confirmed and ex-
panded upon previously reported EsLBP1 localization at 18 h pos-
tinoculation in symbiotic animals (31). EsLBP1 was highly abun-
dant throughout the light organ (Fig. 6B). The antibody cross-
reactivity was high in anterior-appendage epithelial cells, as well as
the apical surfaces of pore and duct cells. EsLBP1 protein was also
abundant in the extracellular crypt spaces of symbiotic light or-
gans, the site of long-term colonization by V. fischeri (Fig. 6C).
To determine whether EsLBP1 protein is specific to the light
organ, we also analyzed other epithelial tissues of the squid that
interact with environmental bacteria, including tentacles, gills,
and eyes (Fig. 6D to F). We found that the protein is not exclusive
FIG 2 Binding of EsLBP1-His6 to MAMP substrates. (A) Results of capture
assay with EsLBP1-His6 medium or control medium incubated with
5,000 cpm 3H-labeled Neisseria LOS and pelleted to nickel beads. (B) Results of
competition experiment for 0.3 nM EsLBP1-His6 or control medium,
5,000 cpm 3H-labeled Neisseria LOS, and 0 to 100-fold excess by weight of
unlabeled N. meningitidis LOS, V. fischeri LPS, or F. tularensis LPS. (C) As
described for panel A but measuring capture of 1,000 cpm 3H-labeled TCT.
(D) As described for panel A but measuring capture of 5,000 cpm [3H]LOS:
CD14 aggregates; EsLBP1-His6 was diluted with control medium such that all
treatments had a constant total volume of conditioned medium. Error bars
indicate standard errors of the means (SEM) of three technical replicates.
Statistical comparisons by ANOVA and pairwise tests compare capture by
EsLBP1-His6 medium to corresponding volume of control medium (A or C)
or the sole control reaction (D); in panel B, comparisons are to the capture
assay with LBP1-His6 medium and no competing unlabeled endotoxin (bars
labeled 0). ***, P  0.001.
FIG 3 Effect of EsLBP1 on viability of E. coli. Shown are CFU of E. coli strain
PL2 after treatment of log-phase culture for 1 h with 30 nM hBPI-21 (N-
terminal fragment of human BPI), 30 nM hLBP (human LBP), or 30 nM
EsLBP1 or no protein. Error bars indicate SEM of 5 matched biological repli-
cates. Significant differences found by ANOVA and pairwise tests are indicated
as follows: **, P  0.01; *, P 0.05.
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to the light organ but is abundant along the apical surfaces of
many or perhaps all epithelia but absent in deeper tissues, such as
muscle. The signal was not seen in light organs or other tissues
treated with preimmune serum (Fig. 6G).
DISCUSSION
In this study, we provide evidence based on both functional assays
and structural modeling that is consistent with EsLBP1 function-
ing as an LBP-like protein. Most notably, EsLBP1 binds Gram-
negative bacterial LOS and LPS with nanomolar or higher avidity
under in vitro conditions, i.e., when LPS/LOS is presented as part
of supramolecular assemblies containing LPS-rich lipid-water in-
terfaces, as in aggregates of purified LPS/LOS. eslbp1 gene expres-
sion is regulated by exposure to the peptidoglycan monomer TCT,
which synergizes with LPS in the triggering of V. fischeri-induced
morphogenesis of the host symbiotic tissues. The gene is expressed
and the protein produced across the organ’s epithelia—from the
point where V. fischeri initially gathers, along the path of its mi-
gration, to where it takes up permanent residence in the crypts.
The protein is also abundant along the apical surfaces of other
epithelial tissues, where colonization by bacteria does not occur.
Although EsLBP1 has only ~25% primary structure identity
with mammalian LBPs in the N-terminal domain (Fig. 1A) and
~21% overall, several key structural features likely important for
LPS-related functions are predicted to be conserved. These fea-
FIG 4 eslbp1 transcript induction by V. fischeri colonization or MAMPs. (A)
Normalized eslbp1 transcript levels in E. scolopes light organs at 4, 8, 12, and
24 h postinoculation with V. fischeri are represented as the ratio of transcript
levels in symbiotic (Sym) light organs and control, aposymbiotic (Apo) light
organs. ***, P  0.001. (B) Normalized eslbp1 transcript levels in light organs
of aposymbiotic and symbiotic animals at 24 h postinoculation as in the ex-
periment whose results are shown in panel A, along with the levels in uninocu-
lated animals treated for 24 h with lipid A (10 ng/ml) from V. fischeri (Vf) or
E. coli (Ec). (C) eslbp1 transcript levels in light organs of aposymbiotic and
symbiotic animals at 24 h postinoculation as described for panel A, along with
the levels in uninoculated animals treated for 24 h with lipid A (10 ng/ml) from
V. fischeri and/or TCT (1 M). (B and C) Small letters indicate statistically
indistinguishable groups of treatments as determined by ANOVA and pairwise
comparison (P  0.01 in all cases). Error bars indicate SEM of three replicates
(A) or four replicates (B and C).
FIG 5 Localization of eslbp1 transcripts in light organs after 24 h of coloni-
zation with V. fischeri. (A) Overview of a symbiotic light organ at 24 h. (B)
Micrograph of pore/anterior appendage region of symbiotic light organ at
24 h. (C) Pore/anterior appendage region of aposymbiotic light organ at 24 h.
(D) Deep crypt region of symbiotic light organ at 24 h. (E) Deep crypt region
of aposymbiotic light organ at 24 h. aa, anterior appendage; dc, deep crypt; p,
pore; red, eslbp1 HCR probe; blue, hsp90; green, V. fischeri 16S ribosomal
subunit.
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tures include (i) the localization of the most cationic region of
these proteins within the predicted outer tip of the N-terminal
domain of these proteins (Fig. 1C to E), albeit with substitutions in
some specific cationic residues that are conserved in mammalian
LBP and BPI, (ii) the extended configuration of the holoproteins,
possibly important for the coordinated binding of LPS-rich supra-
molecular assemblies by the N-terminal domain and delivery of
LPS to specific host targets mediated by the C-terminal domain,
and (iii) the presence of conserved cysteines (140 and 175) within
the N-terminal domain that form a disulfide linkage necessary for
protein stability and function (38). Replacements of specific cat-
ionic residues conserved in mammalian LBP and BPI are common
in proteins of this family in many nonmammalian vertebrates and
invertebrates, including the Atlantic cod Gadus morhua and mol-
lusks Crassostrea gigas (oyster) and Biomphalaria glabrata (snail)
(28, 39, 40), reinforcing the notion that the overall charge of the
region is critical. Remarkably, the much lower avidity of mamma-
lian LBP and BPI for F. tularensis LPS compared to their avidity for
meningococcal LOS (35) is also manifest with EsLBP1 (Fig. 2B).
These data suggest similar determinants of LPS interaction with
the mammalian and squid proteins. In addition, they are consis-
tent with a key role of electrostatic interactions between cationic
regions of the proteins and anionic moieties at or closely neigh-
boring the lipid A region of most LPS/LOS species that are less
prominent in F. tularensis LPS (41). It is noteworthy that the qual-
ity of the 3-D model of EsLBP1 is strongest within the core of the
boomerang-shaped structure that is unique to the LBP/BPI family
(22, 34). Regions of EsLBP1 that diverge from the human BPI 3-D
structure template are generally at the periphery of the molecule.
Divergence at the N terminus could reflect greater intrinsic mo-
bility of the LPS-binding region to optimize interactions with di-
verse LPS-rich bacterial interfaces, and divergence at the C termi-
nus may correspond to functional regions that have evolved to
recognize different (e.g., host) targets. It is also noteworthy that
the predicted structure of EsLBP1 within the C-terminal domain
resembles that of mammalian LBP (34) more than that of BPI (22,
42), lacking the A= helix present in BPI and instead forming a loop
in this region that is displaced relative to the corresponding region
of BPI (Fig. 1B).
The regulation of lbp gene expression by TCT and not LPS was
unexpected, given that in mammalian systems, LPS increases lbp
expression (43, 44); we are not aware of experiments showing the
effect of peptidoglycan treatment on mammalian lbp transcript or
protein levels. Recent studies have indicated that LPS preparations
are often contaminated with trace amounts of peptidoglycan,
which can actually be the element that is active (45). In light of the
results in the squid system, a revisit of the MAMP induction of
genes encoding mammalian LBP/BPI may be fruitful. Regulation
of an LBP by TCT is of added interest, as it is the converse of the
regulation of expression of a well-studied C-type lectin, RegIII.
FIG 6 Localization of EsLBP1 protein in light organs at 18 h. Juvenile E. scolopes squid were colonized with V. fischeri for 18 h and then probed with chicken
anti-EsLBP1 antibody. (A) E. scolopes hatchling under white light, ventral view Light organ is transparent structure immediately ventral to ink sac. Bottom, key
to color coding for labeling of tissues in panels B to G: green, anti-LBP1 antibody or preimmune control (detected by goat anti-chicken FITC secondary
antibody); red, actin (rhodamine-phalloidin); blue, DNA (TOTO-3). (B) Immunocytochemistry micrograph overview of a symbiotic light organ and closely
associated viscera at 18 h, highlighting anti-EsLBP1 antibody staining. p, pore; aa, anterior appendage. (C) Higher-magnification micrograph of deep crypt spaces
of symbiotic light organ. dc, deep crypt lumen. (D to F) High-magnification micrographs of non-light organ tissues: tentacles, gills, and outer surface of eye,
respectively. (G) Preimmune IgY control for EsLBP1 antibody at anterior appendage.
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This protein is expressed in the intestinal epithelium of mice,
binds peptidoglycan, and is preferentially bactericidal against
Gram-positive bacteria (46, 47). However, the expression of the
gene encoding RegIII is induced by the presence of Gram-
negative bacteria or LPS (47, 48).
Cross talk and synergy between MAMPs and their receptors
have been observed elsewhere in mammalian systems. TCT and
lipid A act synergistically in the case of nitric oxide synthase in-
duction during Bordetella pertussis infection of hamster tracheal
cells (49, 50); in this case, TCT and lipid A are thought to deliver
their signal through parallel pathways. In contrast, a sequential
priming effect of peptidoglycan on the LPS response has been
noted in human blood; the administration of staphylococcal pep-
tidoglycan increases the response to subsequent LPS treatment,
apparently through upregulation of such factors as CD14 and
Toll-like receptor 4 (TLR4) on monocytes (51). Our experimental
results suggest a similar mechanistic relationship in the squid,
wherein increased eslbp1 gene expression induced by TCT pro-
motes developmental responses induced by LPS and thus results
in the LPS-peptidoglycan synergy in squid-vibrio symbiosis that
has been described (4). This synergy may be particularly impor-
tant given the relatively low potency of the V. fischeri LPS (52),
presumably related to its unusual acyl chain and O-antigen struc-
ture (53, 54), which may serve to protect the host from endotox-
icity. TCT’s induction of eslbp1 is another example of peptidogly-
can products from beneficial bacteria influencing host immune
development. In mammals, the diverse effects attributed to the
peptidoglycan of the microbiota include maturation of the gut-
associated lymphoid tissues (reviewed in reference 55).
Although the irreversible signal for light organ morphogenesis
is delivered by MAMP-host cell interactions in the crypt spaces,
cell death does not occur in these epithelia. Instead, at ~12 h, the
MAMPS remotely trigger an irreversible program of cell death
that results in a 4- to 5-day regression of the superficial ciliated
epithelia, which are several cell layers away from the crypts (56).
eslbp1 is significantly upregulated at this 12-h time point (Fig. 4A),
and thus, its expression is plausibly timed to play a role in the
transmission of this signal. Furthermore, the crypt epithelia have
an abundance of this protein (Fig. 6C), a finding reminiscent of
the observation of LBP in the mucus of mouse intestines (9).
Our studies of EsLBP1 show that it is not exclusively a light
organ protein but, rather, is abundant in most if not all epithelia
(Fig. 6D to F). These data suggest that the light organ has recruited
LBP as a protein to signal the presence of a mutualistic partner or
control its population rather than to respond to a pathogen. The
hypothesized signaling role for EsLBP1 is unproven but is sup-
ported by EsLBP1’s structural and functional properties, which
resemble mammalian LBP more closely than BPI. These features
include its predicted near-neutral isoelectric point (28) and the
absence of bactericidal activity (Fig. 3), which are distinguishing
features of mammalian LBP compared to BPI (12).
In mammals, LBP can either promote LPS-triggered inflam-
mation or blunt it by promoting noninflammatory clearance
mechanisms (6, 11–14, 57). The former seems entirely CD14 de-
pendent, whereas the latter is largely CD14 independent. No
CD14 has been detected among E. scolopes transcripts, although
transcripts with an MD-2-related lipid-recognition (ML) domain
have been noted (30). The inability of EsLBP1, unlike mammalian
LBP, to interact with monomeric LOS:soluble CD14 complexes
(Fig. 2D) leaves open the possibility of an alternative target of
EsLBP1-LPS complexes. In mammals, up to 100-fold increases in
extracellular LBP levels can promote “silent uptake” of LPS rather
than activation of inflammation (10, 11, 14). Thus, future studies
in the squid will also need to investigate whether induced increases
in EsLBP1 levels also have more complex effects on the evolution
of the symbiotic response and relationship.
The presence of multiple proteins in the LBP/BPI family in
E. scolopes that are predicted to have various biochemical proper-
ties (28) raises the possibility that the squid, like mammals, ex-
presses both LBP-like and BPI-like proteins whose expression and
functions are differentiated in a way to best coordinate host re-
sponses to Gram-negative bacterial interaction, in this case lead-
ing to E. scolopes-Vibrio fischeri symbiosis. If so, this system would
provide the first example outside mammals of the coexistence of
both LBP- and BPI-like family members in a single species. Future
studies of this family of lipid (LPS)-binding proteins during
E. scolopes-V. fischeri symbiosis should advance the understanding
of both the evolution and structure/function of the LBP/BPI fam-
ily and its role in mutualism. LBP may also play important roles, as
yet mostly unknown, in others of the innumerable beneficial
animal-bacterial associations.
MATERIALS AND METHODS
Alignment of EsLBP1 with mammalian LBP and BPI. Human BPI
(NCBI accession no. CAD99178.1), human LBP (AAB31143.1), and Es-
LBP1 (JF514880.1) sequences were aligned using ClustalW2 (58, 59).
LBP/BPI family N-terminal domains were defined by SMART (60). A 3-D
model of EsLBP1 was formed with SWISS-MODEL (61–64); the model
with the best QMEAN4 score (33) was chosen. Images were generated
with PV, a Java Script Protein Viewer (http://dx.doi.org/10.5281
/zenodo.12620), and VMD 1.9.2 (65).
Expression of EsLBP1 in insect cells. The complete open reading
frame of EsLBP1 was amplified from E. scolopes cDNA using primers
LBP1pBAC3F (5=ATACACCATGGTAATGTCTTGCCCCACTCAA
3=) and LBP1pBAC3R (5=TATCACTCGAGAATAGATGTAATTGCC
AAGTC3=). Two single-nucleotide polymorphism (SNPs) resulting in
amino acid substitutions relative to the published EsLBP1 sequence,
T253S (a change of T to S at position 253) and A218T, were consistently
noted in this cDNA preparation and were included in the expressed re-
combinant EsLBP1. The PCR product was digested with EcoRI and XhoI
and ligated into the plasmid pBAC-3 (EMD Millipore, Billerica, MA),
adding a leader peptide and His6 tag, and sequenced. The construct was
transfected into and expressed from Sf9 insect cells by Kinnakeet Biotech-
nology (Midlothian, VA). Conditioned medium from these cells was blot-
ted with anti-tetra-His antibodies (Qiagen), by which means the concen-
tration of EsLBP1 in the undiluted medium was estimated at 2 M.
Control medium including His-tagged E. coli -glucuronidase was pre-
pared from cells transfected with the BacMagic3 transfection control plas-
mid (EMD Millipore).
Preparation of MAMPs. [3H]LOS (5,000 cpm/ng LOS) and [14C]LOS
(6 cpm/ng LOS) were extracted and purified from metabolically labeled
Neisseria meningitidis and used as aggregates of purified LOS as described
previously (66). The [14C]LOS was used as unlabeled LOS in competition
experiments with [3H]LOS (Fig. 2B). Metabolic labeling with radiola-
beled acetate yielded equivalent radiolabeling of all LOS molecules (67).
Unlabeled lipopolysaccharide and lipid A from wild-type V. fischeri, F. tu-
larensis, and N. meningitidis were prepared by the water-phenol method
(68); diphosporyl E. coli lipid A was purchased from Sigma Aldrich (St.
Louis, MO). LPS and LPS derivative stock solutions were sonicated before
use as previously described (52); preparations used in animal experiments
were initially solubilized at 1 mg/ml in 10-mM PIPES [piperazine-N,N=-
bis(2-ethanesulfonic acid)] buffer, pH 6.3, before dilution. Unlabeled
TCT was purified from Bordetella pertussis (69); endotoxin contamination
was undetectable as assayed with Pyrochrome chromogenic reagent (As-
An LPS-Binding Protein in Establishment of a Mutualism
September/October 2015 Volume 6 Issue 5 e01193-15 ® mbio.asm.org 7
sociates of Cape Cod, East Falmouth, MA). To prepare [3H]TCT, pepti-
doglycan of N. gonorrhoeae strain kh619 (MS11 ldcA) was metabolically
labeled using [6-3H]-glucosamine (70) and sacculi were purified as de-
scribed previously (71). [3H]TCT was produced by digestion of sacculi
with gonococcal LtgD, and TCT was purified by reversed-phase high-
performance liquid chromatography (HPLC) (71).
EsLBP1— endotoxin, TCT, and LOS:CD14 complex binding assays.
Conditioned medium containing EsLBP1 was used in parallel with equal
volumes of control (-glucuronidase-containing) conditioned medium
(Fig. 2A and B) or diluted with control conditioned medium (Fig. 2D) to
permit the testing of a range of EsLBP1 concentrations. Medium contain-
ing EsLBP1 or control medium was mixed with a 3H-radiolabeled N. men-
ingitidis MAMP, either 5,000 cpm of LOS (Fig. 2A) or LOS complexed
with human CD14 (13) (Fig. 2C), or 1,000 cpm TCT (Fig. 2D), along with
0.1% human serum albumin in Dulbecco’s phosphate-buffered saline
(PBSA) in 0.2-ml reaction mixture volumes and incubated for 30 min at
27°C. Ten microliters of Ni2-agarose resin was added, the reaction mix-
tures were brought to 0.5 ml total with PBSA, and the reaction mixtures
were incubated on a rotating wheel for an additional 30 min. The beads
were pelleted by gentle centrifugation for 1 min and washed twice with
PBSA for 5 min each. Recovery of radiolabeled material in each of the
recovered fractions was measured by liquid scintillation spectroscopy.
Cocapture of radiolabeled material was calculated as the percentage of the
total recovered radioactive material present in beads. For competition
experiments (Fig. 2B), unlabeled LOS/LPS was preincubated with
0.33 nM EsLBP1 for 30 min at 27°C before the addition of 3H-LOS and
incubation and cocapture as described above.
Assay for bactericidal activity of proteins. Cultures of E. coli strain
PL2 were grown in tryptic soy broth (TSB) at 37°C to mid-log phase and
then diluted 100-fold in TSB with no recombinant protein or 30 nM of
one of the following: hBPI-21 (N-terminal fragment of human BPI),
hLBP (human LBP) (both from Xoma, Berkeley, CA), or EsLBP1. Cul-
tures were incubated for a further 60 min at 37°C. Aliquots of each culture
were diluted 1:6,250, and 10-l amounts were plated in triplicate on tryp-
tic soy agar and incubated overnight at 37°C, and then CFU were counted.
General procedures for animal experiments. Adult E. scolopes ani-
mals were collected from the sand flats of O’ahu, HI, and transported and
maintained as described in previous publications (72); experiments used
newly hatched juveniles in artificial seawater collected from the table on
which they hatched. Symbiotic animals were exposed to ~5,000 CFU/ml
of V. fischeri strain ES114 (73); aposymbiotic animals were not. Symbiosis
was verified with luminescence using a TD-20/20 luminometer (Turner
Designs, Sunnydale, CA). In MAMP treatment experiments, lipid A was
used at 10 ng/ml and TCT at 1 M.
qRT-PCR. We stabilized light organ tissues, extracted RNA, prepared
cDNA, and conducted quantitative reverse transcriptase PCR (qRT-PCR)
experiments in accordance with MIQE guidelines (74), as described pre-
viously (75), except that qRT-PCR used the gene-specific primers given in
Table S1 in the supplemental material and the protocol used was 3 min at
94°C and 40 cycles of 15 s at 94°C, 20 s at 59°C, 20 s at 68°C. We used the
comparative quantification cycle (Cq) method to determine expres-
sion levels (76). eslbp1 levels were normalized to the mean levels of control
transcripts for the 40S ribosomal subunit and serine hydroxymethyltrans-
ferase (HMT).
HCR-FISH. Hybridization chain reaction-fluorescent in situ hybrid-
ization (HCR-FISH) was used to visualize transcripts of E. scolopes and
V. fischeri genes and was performed according to established protocols
(77). All animals examined were collected at 24 h after exposure to V. fis-
cheri strain ES114. The E. scolopes transcripts probed were those of eslbp1
and hsp90, used as a counterstain for E. scolopes tissue. 16S ribosomal
subunit transcripts were probed to counterstain for V. fischeri. Probe se-
quences are given in Table S2 in the supplemental material.
Immunocytochemistry. Immunocytochemistry for EsLBP1 in 18-h
postinoculation hatchlings was performed with chicken anti-EsLBP1 an-
tibody and viewed with an LSM510 laser-scanning confocal microscope
(Zeiss, Thornwood, NY) as described previously (31), except that the
primary antibody incubation was reduced to 7 days. The fluorophores
included goat anti-chicken fluorescein isothiocyanate (FITC) antibody
(for EsLBP1), rhodamine-phalloidin (actin cytoskeleton), and TOTO-3
(DNA).
Statistics. For experiments with quantitative comparisons, with the
sole exception of comparison of CFU levels (Fig. 3), data were log trans-
formed to provide for normality prior to statistical analysis. In the time
course experiment, the highest eslbp1 level from each treatment was re-
moved as an outlier (Fig. 4A). Comparisons between treatments were
made with analysis of variance (ANOVA) (repeated measures ANOVA for
CFU), followed by post hoc pairwise comparisons with Tukey multiple
comparisons of means.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
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